CAMBRIDGE, Mass., May 25, 2017 -- Novaseek Research Inc., a health IT for life sciences company, today announced that it was awarded the Top 10 Clinical Data Management Solution Provider 2017 award by Pharma Tech Outlook. The award recognizes 10 companies at the forefront of providing clinical data management solutions for the pharmaceutical industry and impacting the marketplace.
“Novaseek Research stands out for its solution, the Clinical Data Network for Research (CDNR) platform, that is at the forefront of tackling challenges and is among the leading companies that are real trailblazers in creating benchmarks to be followed,” said Max Wilson, editorial team, Pharma Tech Outlook.
Novaseek Research was selected for the Top 10 Clinical Data Management Solution Provider Award by a panel of experts and members of Pharma Tech Outlook's editorial board.
“We are honored to be recognized as a cutting-edge clinical data management solution provider by Pharma Tech Outlook,” said Dr. Kate Torchilin, CEO, Novaseek Research. “Through our CDNR platform, Novaseek is seeking to leverage the power of real world clinical data to facilitate getting better medicines to patients faster.”
CDNR is an award-winning, cloud-based platform that transforms the way healthcare organizations and consented patients share biospecimens and clinical data with the research community. Researchers access CDNR via an intuitive user interface that gives them the ability to define patient cohorts and request biospecimens using population analytics and detailed criteria such as demographics, diagnoses, co-morbidities, lab values, medications and treatment histories.
The CDNR makes it possible for Novaseek and its hospital partners to serve complex requests, such as, for example, biospecimens and data collected before and after specific cancer treatments, without the need to burden patients with extra blood draws or complex medical questionnaires. This streamlined approach accelerates research and allows more hospitals and patients to participate in supporting biomedical research.
Novaseek was featured in the May 2017 edition of Pharma Tech Outlook. Click here for access to the print article and here for access to the online version.
About CDNR
Novaseek’s award-winning novel cloud platform, the Clinical Data Network for Research (CDNR), easily interfaces with hospital data sources in real time and enables researchers to define patient cohorts through population analytics and to access consented biospecimens and clinical data to advance translational medicine, clinical development and observational studies.
About Novaseek
Novaseek Research, Inc. is a game-changing health IT for life sciences company that provides turn-key, dynamic access to real world clinical data and biospecimens from a network of healthcare organizations. We envision a world where a clear understanding of real-world patients is central to every stage of life sciences research and drug development. For more information, please visit www.novaseekresearch.com.
Media Contact: Terri Clevenger Continuum Health Communications [email protected] (203) 856-4326


SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs
Bob Iger Plans Early Exit as Disney Board Prepares CEO Succession Vote
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI
Meta Stock Surges After Q4 2025 Earnings Beat and Strong Q1 2026 Revenue Outlook Despite Higher Capex
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom
Amazon Stock Dips as Reports Link Company to Potential $50B OpenAI Investment
Nvidia’s $100 Billion OpenAI Investment Faces Internal Doubts, Report Says
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns
Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring
Chinalco and Rio Tinto Acquire Controlling Stake in Brazil’s CBA for $903 Million 



